{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:42:17Z","timestamp":1793389337968,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PRA"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Chronic myeloid leukemia is characterized by the presence of the Philadelphia\nchromosome, which is caused by the breakpoint cluster region-Abelson fusion or joined gene.\nA high concentration of BCR-ABL transcripts level can strongly forecast cytogenetic and hematologic\nreversion in CML patients. However, the molecular test for BCR-ABL is costly and hardly\navailable in developing countries with low and middle-income. Owing to this, it is required to examine\nother cost-effective and best diagnostic (prognostic) biomarkers.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The present study aimed to estimate the total LDH and uric acid level as compared to\nBCR-ABL transcript level among treated and treatment-naive Chronic Myeloid Leukemia (CML)\npatients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A comparative cross-sectional study design was used to include eighty-one (81) CML patients\ntested for BCR-ABL by GeneXpert RT-PCR transcript level at Tikur Anbessa Specialized\nHospital. The current study correlates LDH with BCR-ABL and hematological parameters using\nthe spearman correlation, Mann-Whitney U test, and roc curve data analysis tool.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Result:<\/jats:title>\n<jats:p>A total of 81 CML patients were assayed; 46(56.8%) of them were in the medically treated\ngroup, and the remaining 35 (43.2%) were treatment-naive patients. Significant positive correlations\nwere observed between LDH and BCR-ABL (r=0.79, P&lt;0.001).The correlation coefficient\nvalue of uric acid (r=0.295, p&lt;0.008) with BCR-ABL showed a weak correlation between the two\ntest parameters. There was a statistically noteworthy (p&lt;0.05) difference in the median level of\nBCR-ABL and LDH among patients in the treatment group (median=21%, 350 U\/L) and the treatment-\nnaive group (median=57%, 1246 U\/L), respectively. For uric acid, there was no statistically\nsignificant (p&lt;0.542) difference between the study group. The AUC for LDH, Basophil, and WBC\nwas 0.881, 0.889, and 0.748, respectively, which showed better performance for the follow-up of\npatients with CML than uric acid (0.695) and platelets (0.70).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The CML LDH value strongly correlated with BCR-ABL transcript level, whereas\nuric acid was weakly correlated with BCR-ABL. Hence, in parallel with the BRC-ABL transcript\nlevel, these findings could be a patent for confirming the capability of LDH as an alternative cost--\neffective diagnostic, prognostic biomarker, and a novel therapeutic target in CML disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574892816666210222152126","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T05:29:25Z","timestamp":1614058165000},"page":"445-455","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients"],"prefix":"10.2174","volume":"16","author":[{"given":"Temesgen Sisay","family":"Hailemariam","sequence":"first","affiliation":[{"name":"Department of Medical Laboratory, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box: 9086, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2114-9325","authenticated-orcid":true,"given":"Mohammed","family":"Mehdi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kinde","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box: 9086, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seifu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe","family":"Edao","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory, School of Medicine, College of Health Sciences, Addis Ababa University, P.O. Box: 9086, Addis Ababa, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Recent Patents on Anti-Cancer Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/191704","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191704\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/191704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T13:58:23Z","timestamp":1635775103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191704\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574892816666210222152126","relation":{},"ISSN":["1574-8928"],"issn-type":[{"value":"1574-8928","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}